Essential Drugs Monitor No. 031 (2002)
(2002; 72 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentEssential Drugs Monitor
Ouvrir ce répertoire et afficher son contenuEditorial
Ouvrir ce répertoire et afficher son contenuConflict of Interest
Afficher le documentLetter from the Editor
Ouvrir ce répertoire et afficher son contenuNews Desk
Afficher le documentNetscan, Meetings & Courses
Ouvrir ce répertoire et afficher son contenuResearch
Ouvrir ce répertoire et afficher son contenuDrug Promotion
Ouvrir ce répertoire et afficher son contenuNational Drug Policy
Ouvrir ce répertoire et afficher son contenuAccess
Ouvrir ce répertoire et afficher son contenuRational Use
Ouvrir ce répertoire et afficher son contenuAccess
 

Essential Drugs Monitor

The Essential Drugs Monitor is produced and distributed by the WHO Department of Essential Drugs and Medicines Policy (EDM). It is published in Chinese, English, French, Spanish and Russian, and has a global readership of some 300,000 to whom it is free of charge. The Monitor carries news of developments in national drug policies, therapeutic guidelines, current pharmaceutical issues, educational strategies and operational research.

WHO's Department of Essential Drugs and Medicines Policy seeks to ensure that all people - wherever they may be - are able to obtain the drugs they need at a price that they and their country can afford; that these drugs are safe, effective and of good quality; and that they are prescribed and used rationally.

All correspondence should be addressed to:

The Editor
Essential Drugs Monitor
World Health Organization
CH-1211 Geneva 27, Switzerland
Fax: +41 22-791-4167
e-mail: medmail@who.int

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013